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  An  herbal  extract  mixture  and  yogurt  added  to  the 
herbal extract mixture were tested for their protective and 
therapeutic  effects  on  ethanol-induced  liver  injury.  The 
herbal extract mixture, yogurt and commercial drugs were 
used for treatment for two weeks prior to administering a 
single oral dose of ethanol (3 g/kg body weight). The herbal 
extract  mixture  and  yogurt  added  to  the  herbal  extract 
mixture were found to provide protection against ethanol- 
induced toxicity comparable to the commercial drug treat-
ment, according to the serum and histopathological analysis. 
It  was  also  shown  that  co-treatment  with  herbal  extract 
mixture and yogurt against a triple oral dose of ethanol (2 
g/kg  body  weight,  over  one  week)  provided  protection 
against ethanol toxicity. After the initial set of experiments, 
the  herbal  extract  mixture  and  yogurt  treatments  were 
extended  for  three  more  weeks.  When  compared  to  the 
positive  control,  further  treatment  with  both  the herbal 
extract and yogurt significantly reduced liver injury and 
resulted in a lower grade of lipid deposition. 
Keywords: ethanol-induced toxicity, herbal extract mixture, pro-
tective effect, rat, yogurt 
Introduction 
  Functional foods and food additives are substances that 
provide health benefits beyond basic nutrition due to 
certain physiologically active components. Some of these 
substances may help prevent disease, reduce the risk of 
developing disease, or enhance general health, especially 
in the liver. Consumer interest in functional foods has  
increased during the late twentieth century as people have 
become more focused on achieving and maintaining a 
healthy lifestyle  [9].
  Alcoholic liver disease (ALD) remains a serious health 
problem. ALD is a common consequence of prolonged and 
heavy alcohol intake. Changes fatal to the liver include 
fatty liver, hepatitis and hepatic cirrhosis [5,6,12]. Multiple 
mechanisms are likely to be involved in the pathogenesis 
of these problems; especially those associated with the 
toxic substances generated during alcohol metabolism. 
Accumulated evidence has demonstrated that both oxidative 
stress and abnormal cytokine production are important 
factors in the development of alcoholic liver damage [2, 
3,8]. 
  Although much progress has been made in understanding 
the pathogenesis of alcoholic liver disease, there remains 
no effective therapy for this disease. In the absence of 
reliable drugs to protect the liver, herbs may play role in 
treating liver disorders. Many plants and herbal extracts 
demonstrate hepatoprotective activity; hence, many 
attempts have been made to formulate herbal preparations 
as functional foods [5,9]. 
  This study was undertaken to investigate the protective 
and therapeutic effects of an herbal extract mixture and 
yogurt added to the herbal extract mixture on ethanol 
induced hepatic injury in a rat model.32    Min-Won Baek et al.
Materials and Methods
Animals
  Four week old male SD rats weighing 190-200 g were 
purchased from SLC (Japan) and maintained in a barrier 
room with a 12：12 h light and dark cycle. The room 
temperature (22 ± 1
oC) and humidity (55 ± 5%) were 
controlled automatically. Laboratory pellet chow (Purina, 
Korea) and water were given ad libitum. All of the animals 
were acclimatized for one week prior to the experiment. 
The procedures involving the animals and their care were 
carried out according to the Guidelines for the Care and 
Use of Laboratory Animals of Seoul National University, 
Korea. 
Materials
  The herbal extract mixture was composed of two herbal 
extracts (alder tree extract: Alnus japonica Steud, labiate 
herb extract; Prunella vulgaris var. lilacina Nakai), two 
fermented ingredients (milk thistle extract, green bean-rice 
bran fermentation extract) and turnip concentrate. The 
herbal extract mixture preparation included the following: 
100 g of the xylem and bark from a dried alder tree was 
added to 1,000 g of water, then boiled at 100
oC for 1-5 h. 
The solution was filtered through a 5 µm filter to acquire 
500 g of an alder tree extract. Fifty grams of the dried 
labiate herb was boiled at 100
oC in 1,000 g of water for 1-5 
h, followed by filtration through a 400 mesh filter to 
produce 600 g of labiate herb extract. Milk thistle extract 
was purchased in powder form (TGS, Japan) and had, by 
weight, a total flavonoid content of 80-95% and 28-32% 
sylibin content. In addition, a liquid green bean-rice bran 
fermentation extract was purchased (Toyo Hakko, Japan) 
along with a liquid turnip concentrate (34-36%) (KangHwa 
Product, Korea).
  In this study, two different doses (1 × and 2 ×) of herbal 
extract mixture and yogurt were used. The herbal extract 
mixture 1 × with the dose of the yogurt additive, was 
expected to be put on the market. The herbal extract 
mixture 2 × had a two-fold concentration. The commercial 
drug (Legalon; Bukwang Pharm, Korea) consisted of 
sylibin (Carduus marianus extract) was used as a control. 
The ethanol purchased from the Sigma-Aldrich (USA).
Experiment design
  To examine protective and therapeutic efficacy of the 
herbal extract mixture and yogurt, we carried out two 
animal experiments as follows:
  Protective effects of herbal extract mixture with a single 
ethanol challenge: For the herbal extract mixture, the rats 
were divided into four groups (herbal extract mixture 1 ×, 
herbal extract mixture 2 ×, negative, and positive control 
groups) containing five animals each. Before inducing 
ethanol toxicity, the negative and positive control groups 
received PBS 5 ml/kg body weight (BW) orally once per 
day for two weeks. The herbal extract mixture, 1 × and 2
× treatment groups, was  administered at a dose of 5 ml/kg 
body weight of herbal extract mixture, 1 × and 2 ×, orally 
once per day for two weeks. After the two-week treatment 
period, a single dose of ethanol (50%, 3 g/kg BW) was 
administered orally to all groups except for the negative 
control group. The negative control animals were admini-
stered PBS in equivalent volumes instead of ethanol.
  For the yogurt preparation, the rats were divided into four 
groups (yogurt, commercial drug, negative, and positive 
control groups) containing five animals each. Before 
inducing ethanol toxicity, the negative and positive control 
groups were treated the same as in the herbal extract 
mixture experiment. The commercial drug group was 
administered 70 mg/kg BW (recommended consumption 
dose for adults) in PBS once a day orally during the same 
period. The yogurt treatment groups received 5 ml/kg BW 
of yogurt orally once a day for two weeks.  After the two- 
week treatment, ethanol administration was carried out as 
mentioned above.
  Protective and therapeutic effects of the herbal extract 
mixture and yogurt to triple ethanol challenge: For the 
herbal extract mixture, the rats were divided into four 
groups (herbal extract mixture 1 ×, herbal extract mixture 
2 ×, negative, and positive control groups) containing ten 
animals each. The negative and positive control groups 
were given PBS 5 ml/kg BW orally once per day for one 
week. The herbal extract mixture, 1 × and 2 ×, treatment 
groups were given 5 ml/kg BW of herbal extract mixture, 
1 × and 2 ×, orally once a day for one week. Ethanol 
(50%, 2 g/kg BW) was administered orally to all groups, 
except for the negative control group, once a day on the 
first, fourth and seventh day. The negative control animals 
were given PBS in an equivalent volume instead of the 
ethanol. Ethanol administration was given 30 min after 
the herbal extract mixture and the PBS treatment.
  For the yogurt preparation, the experimental groups were 
the same as the single ethanol challenge. The negative and 
positive control groups were treated the same herbal 
extract mixture triple ethanol challenge. The commercial 
drug group was given 70 mg/kg BW of the drug for the 
liver (recommended consumption dose for adults) in PBS 
once a day orally during the same period. The yogurt 
treatment groups were given 5 ml/kg BW of yogurt once a 
day orally for one week. Ethanol (50%, 2 g/kg BW) 
administration was carried out as mentioned above. Six 
hours later after the last ethanol dose, one-half of all 
animals in the experimental group (five animals) were 
sacrificed and necropsied; liver and blood samples were 
collected on the seventh day.
    To examine the therapeutic properties, the remaining 
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with herbal extract mixture, yogurt and PBS for three 
weeks, in the same way, without ethanol administration.
  All experimental animals were denied food and water for 
5 h prior to treatment. After each treatment, the animals 
were given feed pellets and water ad libitum except on the 
day of necropsy. Clinical evaluation and general appearances 
were noted once daily, and body weights and food 
consumption levels were measured twice per week. Six 
hours after the final administration and treatment, all 
animals were subsequently sacrificed under anesthesia. 
Liver and blood samples were collected for further exami-
nation. 
Serum analysis
  From the collected blood samples, serum alanine amino-
transferase (ALT), aspartate aminotransferase (AST) and 
total bilirubin levels were measured using a standard 
clinical automatic analyzer (Hitachi 7200; Hitachi High- 
Tech, Japan).
Necropsy and histopathology
    Livers from all experimental groups were examined 
immediately and fixed in 10% buffered formalin for 24 h, 
processed in an alcohol-xylene series, embedded in paraffin 
wax, and sectioned at 2 µm. The sections were stained with 
hematoxylin and eosin. The sections were graded for the 
degree of fatty change, inflammation and pericentral 
fibrosis. Steatosis was scored as follows: 1 when less than 
25% of the cells contained fat droplets, 2 when 25-50%, 3 
when 50-75%, and 4 when ＞ 75% contained fat droplets.  
Inflammation was graded 0 to 3, as previously described 
[11]: 1 indicated the presence of scattered inflammatory 
cells, 2 indicated the presence of foci of inflammatory cells 
and 3 corresponded to diffuse inflammation. The sum of 
steatosis and inflammation scores was used in the results. 
Persons unaware of our experimental treatments evaluated 
the liver sections.
Oil red O staining
  Some of the liver tissues were removed and placed in 4% 
paraformaldehyde in PBS for 4 h. Briefly, the tissues were 
rinsed with PBS and cryoprotected by soaking in 40% 
sucrose solution at 4
oC overnight. The tissues were then 
snap-frozen in OCT and stored at 򰠏70
oC. Eight micrometer 
frozen sections were prepared on glass slides (Super FrostPlus; 
Fisher, USA) and stored at 򰠏70
oC. Frozen sections were 
incubated with oil red O, washed with 60% isopropanol 
and then counterstained with hematoxylin. The hepatic 
lipid deposit area (red color), in the stained liver section, 
was analyzed by an image analyzer (TDI Scope Eye 
Version 3.0 for Windows; Olympus, Japan). 
Statistical analysis
  All data (BW, food intake, blood chemistry, histological 
grade, lipid area) are reported as a mean ± SD (n = 5). The 
data was assessed using one-way analysis of variance 
coupled with Duncan's test using the SAS system. A p ＜ 
0.05 was considered significant.
Results
Change of body weight and food consumption
There were no clinical abnormalities in any of the experi-
mental animals during the experimental period.  The BW 
and food consumption levels were similar and showed no 
significant differences (data not shown). However, when 
the ethanol was administered, the food consumption levels 
in the ethanol-treated experimental animals decreased 
slightly when compared to the negative control animals 
(data not shown).
Protective  effects  of  herbal  extract  mixture  and 
yogurt with a single ethanol challenge
  Ethanol-induced liver damage was evaluated by measuring 
liver injury markers (AST, ALT and total bilirubin) and 
assessing histopathological changes.
  For the serum analysis, the herbal extract mixture, 1 × and 
2 ×, treatment group animals showed significantly decreased 
levels of all injury makers compared to the positive control 
animals (Table 1). However, a dose dependent difference 
between the herbal extract mixture, 1 × and 2 ×, was not 
observed. When compared with the commercial drug 
treatment, the AST levels of the animals in the herbal 
extract mixture 2 × treatment group were decreased 
compared to the negative control animals, but by contrast, 
the levels of ALT and total bilirubin were not. However, all 
liver injury makers in the blood were significantly 
decreased with the yogurt treatment (Table 1).
    The livers from the ethanol treated animals showed 
hepatic microvesicular steatosis; the fat accumulated in 
vesicles that displaced the cytoplasm. Hepatocyte necrosis, 
degeneration and lymphocyte infiltration were also 
observed. For the histopathological grading, the herbal 
extract mixture 1 × and 2 × and the yogurt treatment 
groups showed a significantly lower grade when compared 
with the positive control animals; interestingly, the 
commercial drug treatment group did not show a lower 
histopathological grade (Table 1).
Protective and therapeutic effects of herbal extract 
mixture and yogurt with the  triple ethanol challenge
  As shown in Table 2, the triple ethanol administration 
caused a higher increase in all serum injury marker levels 
and a more severe histopathological grade than did the 
single administration. However, one week of treatment 
with the herbal extract mixture, 1 × and 2 × and the yogurt 
preparation reduced the hepatic injury. 34    Min-Won Baek et al.
Table 1. Results from serum analysis and histopathological grade of the protective effect of herbal extract mixture and yogurt to a single
ethanol challenge (n = 5)
Treatments
Serum analysis Histopathological grade
AST
(IU/ml)
ALT
(IU/ml)
Total bilirubin
(IU/ml)
Sum of steatosis and 
inflammation score*
  Herbal extract mixture 
  Yogurt
NC
PC
1×
2×
NC
PC
Drug
Yogurt
  87.2 ± 9.3
a
141.4 ± 11.5
b
108.7 ± 13.4
a
  99.9 ± 2.3
a
  94.3 ± 3.7
a
161.5 ± 7.9
b
121.4 ± 18.4
c
  99.2 ± 6.6
a
34.1 ± 4.9
a
57.5 ± 12.0
b
41.0 ± 16.8
a
38.3 ± 7.6
a
38.6 ± 3.5
a
71.3 ± 8.8
b
43.8 ± 7.3
a
52.7 ± 5.3
c
0.032 ± 0.023
a
0.099 ± 0.041
b
0.051 ± 0.017
a
0.050 ± 0.012
a
0.037 ± 0.013
a
0.156 ± 0.009
b
0.062 ± 0.008
c
0.065 ± 0.007
c
0.1 ± 0.2
a
3.8 ± 0.6
b 
2.3 ± 0.5
c
0.8 ± 0.5
d
0.2 ± 0.2
a
4.2 ± 0.7
b
2.8 ± 1.0
b
2.1 ± 0.7
c
Superscript letters (
a, b, c, d) indicate groups that are significantly different (p ＜ 0.05) from each other. *Scores of steatosis and inflammation
were analyzed through the description of Materials and Methods. NC: negative control, PC: positive control, 1 ×: herbal extract mixture 1 ×
pretreatment, 2 ×: herbal extract mixture 2 × pretreatment, Drug: commercial liver drug pretreatment, Yogurt: yogurt pretreatment.
Table 2. Results from serum analysis and histopathological grade of the protective effect of herbal extract mixture and yogurt to a triple
ethanol challenge (day 7, n = 5)
Treatments
Serum Analysis Histopathological grade
AST
(IU/ml)
ALT
(IU/ml)
Total bilirubin
(IU/ml)
Sum of steatosis and 
inflammation score*
  Herbal extract mixture 
  Yogurt
NC
PC
1×
2×
NC
PC
Drug
Yogurt
  92.1 ± 9.4
a
158.7 ± 11.5
b
136.4 ± 14.8
c
131.5 ± 7.7
c
  94.6 ± 7.0
a
153.9 ± 13.5
b
117.9 ± 7.4
c
124.7 ± 5.8
c
34.3 ± 6.1
a
59.1 ± 14.5
b
43.9 ± 4.6
a
39.2 ± 6.0
a
36.2 ± 5.8
a
60.8 ± 9.4
b
45.8 ± 4.3
c
43.1 ± 6.7
a, c
0.034 ± 0.017
a
0.107 ± 0.039
b
0.059 ± 0.032
a
0.048 ± 0.007
a 
0.041 ± 0.009
a
0.147 ± 0.030
b
0.057 ± 0.022
a
0.068 ± 0.13
a
0.3 ± 0.2
a
4.5 ± 0.4
b
1.8 ± 0.4
c
2.3 ± 0.6
d
0.4 ± 0.4
a
4.8 ± 0.6
b
3.2 ± 0.5
b 
3.1 ± 0.5
c
Superscript letters (
a, b, c, d) indicate groups that are significantly different (p < 0.05) from each other. *Score of steatosis and inflammation were
analyzed through the description of Materials and Methods. NC: negative control, PC: positive control, 1 ×: herbal extract mixture 1 ×
treatment, 2 ×: herbal extract mixture 2 × treatment, Drug: commercial liver drug treatment, Yogurt: yogurt treatment.
Serum and histopathological analysis
    The serum analysis showed that the herbal extract 
mixture, 1 × and 2 ×, treatment did not reach dose- 
dependent significance, but did indicate a trend. The 
yogurt treatment did not reduce the levels of AST or total 
bilirubin similar to the results of the commercial drug. On 
the other hand, the ALT levels in the herbal extract mixture 
and yogurt treatment group showed a further decrease 
when compared to the commercial drug treatment (Table 
2).
  The histopathological  grade also showed a significant 
reduction in  steatosis and inflammation in accordance 
with the yogurt treatments, but the commercial drug 
administration did not reduce the histopathological lesions 
as did the herbal extract mixture and yogurt preparations  
(Table 2).
  To investigate the therapeutic effects of the herbal extract 
mixture and yogurt, the animals were treated for an 
additional three weeks with the triple administration of 
ethanol, the herbal extract mixture and the yogurt preparation.
  Two serum markers in the herbal extract mixture and 
yogurt treatment groups (AST and ALT) had lower levels 
on the day seven analysis and these differences were 
statistically significant. However, the total bilirubin 
showed no significant changes. The total bilirubin levels Protective effects of herbal extract mixture against toxicity    35
Fig. 2. Oil red O stain of the liver in the experimental groups. (A)
negative control, (B) positive control, (C) herbal extract mixture
1 × treatment, (D) herbal extract mixture 2 × treatment, (E) com-
mercial liver drug treatment, (F) yogurt treatment, Oil red O 
stain, ×200.
Table 3. Results from serum analysis and histopathological grade of the protective effect of herbal extract mixture and yogurt to triple 
ethanol challenge (day 28, n = 5)
Treatments
Serum Analysis Histopathological grade
AST
(IU/ml)
ALT
(IU/ml)
Total bilirubin
(IU/ml)
Sum of steatosis and 
inflammation score*
  Herbal extract mixture 
  Yogurt
NC
PC
1×
2×
NC
PC
Drug
Yogurt
88.5 ± 5.6
a
117.3 ± 7.1
b
98.7 ± 10.2
a
90.2 ± 6.4
a
91.2 ± 7.8
a
126.5 ± 9.4
b
94.1 ± 8.3
a,c 
104.4 ± 5.1
c
39.0 ± 6.7
a
67.5 ± 5.9
b
47.2 ± 2.8
c
37.4 ± 2.1
a
39.0 ± 6.7
a
67.5 ± 5.9
b
47.2 ± 2.8
a,c
37.4 ± 2.1
c
0.024 ± 0.019
a
0.051 ± 0.012
b,c
0.046 ± 0.011
a,c
0.063 ±0.025
c
0.045 ±0.039
a
0.050 ± 0.025
a 
0.041 ± 0.015
a
0.047 ±0.026
a
0.4 ±0.3
a
1.7 ± 0.5
b
0.5 ± 0.3
a
1.5 ± 0.5
b
0.3 ± 0. 3
a
1.6 ± 0.6
a,b
1.1 ± 0.4
a,b
1.2 ± 0.5
b
Superscript letters (
a, b, c, d) indicate groups that are significantly different (p < 0.05) from each other. *Score of steatosis and inflammation were
analyzed through the description of Materials and Methods. NC: negative control, PC: positive control, 1 ×: herbal extract mixture 1 ×
treatment, 2 ×: herbal extract mixture 2 × treatment, Drug: commercial liver drug treatment, Yogurt: yogurt treatment.
Fig. 1. Histopathology of the liver in the experimental groups (A)
negative control, (B) positive control, (C) commercial liver drug 
treatment, (D) yogurt treatment, H&E stain, ×200.
did not show any trend at the end of experiment (Table 3).
  For the histopathological grading, only the herbal extract 
mixture 1× and yogurt treatment groups showed signi-
ficantly decreased scores. By contrast, the herbal extract 
mixture 2× and commercial drug treatment showed no 
significant changes (Table 3). It was difficult to estimate 
the level of steatosis because of glycogen deposits in the 
liver (Fig. 1). To determine the lipid distribution, oil red O 
staining was carried out and the lipid areas were analyzed 
(Fig. 2 and 3). The lipid accumulation showed only a high 
level in positive control (Fig. 3); however, the herbal 
extract mixture, yogurt and commercial drug treatment 
groups had significantly lower lipid accumulation similar 
to negative control. 36    Min-Won Baek et al.
Fig. 3. Lipid areas in the experimental groups. NC: negative con-
trol, PC: positive control, 1 ×: herbal extract mixture 1 × treat-
ment, 2 ×: herbal extract mixture 2 × treatment, Drug: commer-
cial liver drug treatment, Yogurt: yogurt treatment. The lipid 
areas are presented as the mean ± SD (n = 5). Superscript letters 
(
a, b) indicate groups that are significantly different (p ＜ 0.05) 
from each other.
Discussion
  Ethanol causes toxicity in mice and rats [4,6,14]. The 
factors responsible for ethanol-induced liver injury are the 
levels of unmetabolized acetaldehydes and reactive 
oxygen species (ROS). Acetaldehyde, which is toxic itself, 
is a very unstable ethanol metabolite in living orangims, 
and the release of ROS from hepatocytes induces apoptosis 
[2,10,15]. An overdose of ethanol or chronic alcohol intake  
increases  these toxic compounds  and this results  in acute 
and/or chronic liver disease manifested by  steatosis, 
inflammation and hepatic failure [4,7,11,13]. 
  In this study, a mixture of an herbal extract and yogurt 
additive were tested for their protective and therapeutic 
efficacy against ethanol-induced toxicity in rats. The two- 
week treatment with the herbal extract mixture and yogurt 
subsequent to a single ethanol dose challenge showed 
decreased liver injury in both the serum and histopatho-
logical analysis when compared with the positive control 
animals. The effects were similar to the commercial drug 
treatment. The results also showed that a triple ethanol 
challenge, in the one-week herbal extract mixture and 
yogurt co-treatment as well as the three-week continuous 
treatment, reduced lipid deposition caused by the ethanol- 
induced toxicity. 
  We previously reported that the herbal extract mixture 
had a protective effect against ethanol-induced toxicity in 
a mouse model [1]. In this study, the herbal extract mixture 
and yogurt also showed protective and therapeutic effects 
for the ethanol-induced toxicity in a rat model. The results 
suggest that treatment with an herbal extract mixture and 
yogurt effectively protected and treated the ethanol asso-
ciated liver injury in the rats studied. To determine the 
precise mechanism underlying the efficacy of the herbal 
extract mixture for ethanol toxicity, studies focusing on the 
antioxidant effects  of the herbal extract mixture and its 
neutralizing capabilities at the molecular level are being 
carried out.  
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